Efficacy of Lanadelumab in Hereditary Angioedema Patients Switching From C1 Inhibitor Long-Term Prophylaxis: Interim Results From the HELP Open-Label Extension Study
Journal of Allergy and Clinical Immunology- United States
doi 10.1016/j.jaci.2018.12.114
Full Text
Abstract
Available in
Date
February 1, 2019
Authors
Publisher
Elsevier BV